202 related articles for article (PubMed ID: 17897027)
1. The advance of dendrimers--a versatile targeting platform for gene/drug delivery.
Parekh HS
Curr Pharm Des; 2007; 13(27):2837-50. PubMed ID: 17897027
[TBL] [Abstract][Full Text] [Related]
2. Dendrimers for gene delivery--a potential approach for ocular therapy?
Chaplot SP; Rupenthal ID
J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
[TBL] [Abstract][Full Text] [Related]
3. Emerging vectors and targeting methods for nonviral gene therapy.
Lavigne MD; Górecki DC
Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390
[TBL] [Abstract][Full Text] [Related]
4. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
5. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.
Appaiahgari MB; Vrati S
Expert Opin Biol Ther; 2015 Mar; 15(3):337-51. PubMed ID: 25529044
[TBL] [Abstract][Full Text] [Related]
6. Poly(amidoamine) dendrimer complexes as a platform for gene delivery.
Shcharbin D; Shakhbazau A; Bryszewska M
Expert Opin Drug Deliv; 2013 Dec; 10(12):1687-98. PubMed ID: 24168461
[TBL] [Abstract][Full Text] [Related]
7. Photochemical transfection: a technology for efficient light-directed gene delivery.
Høgset A; Prasmickaite L; Hellum M; Engesaeter BO; Olsen VM; Tjelle TE; Wheeler CJ; Berg K
Somat Cell Mol Genet; 2002 Nov; 27(1-6):97-113. PubMed ID: 12774944
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers as vectors for genetic material delivery to the nervous system.
Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V
Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638
[TBL] [Abstract][Full Text] [Related]
9. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.
Naso MF; Tomkowicz B; Perry WL; Strohl WR
BioDrugs; 2017 Aug; 31(4):317-334. PubMed ID: 28669112
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of gene therapy in the treatment of cardiovascular diseases.
Barbato JE; Kibbe MR; Tzeng E
Crit Rev Clin Lab Sci; 2003 Oct; 40(5):499-545. PubMed ID: 14653356
[TBL] [Abstract][Full Text] [Related]
11. Physical methods for gene transfer: improving the kinetics of gene delivery into cells.
Mehier-Humbert S; Guy RH
Adv Drug Deliv Rev; 2005 Apr; 57(5):733-53. PubMed ID: 15757758
[TBL] [Abstract][Full Text] [Related]
12. Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises.
Kumar VV; Singh RS; Chaudhuri A
Curr Med Chem; 2003 Jul; 10(14):1297-306. PubMed ID: 12678801
[TBL] [Abstract][Full Text] [Related]
13. Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.
Xu Q; Wang CH; Pack DW
Curr Pharm Des; 2010 Jul; 16(21):2350-68. PubMed ID: 20618156
[TBL] [Abstract][Full Text] [Related]
14. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.
Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519
[TBL] [Abstract][Full Text] [Related]
15. Dendrimers and the double helix--from DNA binding towards gene therapy.
Smith DK
Curr Top Med Chem; 2008; 8(14):1187-203. PubMed ID: 18855705
[TBL] [Abstract][Full Text] [Related]
16. Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?
Giacca M
Int J Nanomedicine; 2007; 2(4):527-40. PubMed ID: 18203421
[TBL] [Abstract][Full Text] [Related]
17. Vector-mediated cancer gene therapy: an overview.
Seth P
Cancer Biol Ther; 2005 May; 4(5):512-7. PubMed ID: 15908802
[TBL] [Abstract][Full Text] [Related]
18. Research Progress of nucleic acid delivery vectors for gene therapy.
Jiao Y; Xia ZL; Ze LJ; Jing H; Xin B; Fu S
Biomed Microdevices; 2020 Jan; 22(1):16. PubMed ID: 31989315
[TBL] [Abstract][Full Text] [Related]
19. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
Douglas KL
Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in delivery of nucleic acid-based antiviral agents.
Christopher ME; Wong JP
Curr Pharm Des; 2006; 12(16):1995-2006. PubMed ID: 16787243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
